Feb 26, 2025 / 09:30PM GMT
Operator
Hello. Welcome to VR Biotechnologies' 4th quarter and full year 2024 financial results and business update call. As a reminder, this conference call is being recorded.
At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question, you may press star followed by the number one on your telephone keypad.
To withdraw your question, you may press star followed by the number one again.
I will now turn the call over to Rich Latke, senior director investor relations. You may begin, Mr. Latka.
Richard Lepke - Vir Biotechnology Inc - Senior Director of Investor Relations
Thank you and good afternoon. With me today are Dr. Marianne Deaker, our Chief Executive Officer, Dr. Mark Eisner, our Chief Medical Officer, Jason Byrne, our Chief Financial Officer, and Dr. Mika During, our Executive Vice President of oncology, will be available during the Q&A session.
Before we begin, I would like to remind everyone that some of the statements we're
Q4 2024 Vir Biotechnology Inc Earnings Call Transcript
Feb 27, 2025
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers